Applying switchable Cas9 variants to in vivo gene editing for therapeutic applications (2019)

First Author: Mills E

Attributed to: Switchable gene drives funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s10565-019-09488-2

Publication URI: http://dx.doi.org/10.1007/s10565-019-09488-2

Type: Journal Article/Review

Parent Publication: Cell Biology and Toxicology

Issue: 1